{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:10:20Z","timestamp":1756303820350,"version":"3.44.0"},"reference-count":24,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2018,7,9]]},"abstract":"<jats:p>Hodgkin\u2019s lymphoma (HL) is a type of cancer originating in the lymph nodes. The preferred therapy for advanced HL is a combination of chemotherapies including doxorubicin, bleomycin, vinblastine and dacarbazine (ABVD). ABVD has been standard therapy for advanced HL. It is generally considered as safe and rarely has been reported to cause acute liver failure. We present a case of 79-year-old woman with HL, who developed acute liver failure secondary to first cycle of ABVD chemotherapy.<\/jats:p>","DOI":"10.1136\/bcr-2018-225474","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T09:18:11Z","timestamp":1532942291000},"page":"bcr-2018-225474","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Acute liver failure secondary to ABVD use"],"prefix":"10.1136","volume":"2018","author":[{"given":"Amir","family":"Eslami","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anupama Divakaruni","family":"Mathur","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Geisinger Medical Center, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal Kishor","family":"Jha","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Geisinger Medical Center, Danville, Pennsylvania, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,7,30]]},"reference":[{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.1","DOI":"10.1002\/1097-0142(19930315)71:6<2062::AID-CNCR2820710622>3.0.CO;2-0"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.2","DOI":"10.1200\/JCO.2003.12.086"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.3","DOI":"10.1200\/JCO.2005.03.2151"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.4","DOI":"10.1200\/JCO.2005.04.4644"},{"unstructured":"National Comprehensive Cancer Network (NCCN). NCCN Clinical practice guidelines in oncology. http:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp (accessed on 28 Feb 2018).","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.5"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.6","DOI":"10.1002\/1097-0142(197507)36:1<252::AID-CNCR2820360128>3.0.CO;2-7"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.7","DOI":"10.1200\/JCO.2008.17.0910"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.1987.5.1.27","article-title":"Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin\u2019s disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy","volume":"5","author":"Santoro","year":"1987","journal-title":"J Clin Oncol"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.9","DOI":"10.1002\/1097-0142(19841101)54:9<2006::AID-CNCR2820540937>3.0.CO;2-F"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.10","DOI":"10.1002\/1097-0142(197401)33:1<19::AID-CNCR2820330107>3.0.CO;2-M"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.11","DOI":"10.1038\/clpt.1993.69"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.12","DOI":"10.1038\/bjc.1992.158"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.13","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.14","DOI":"10.7326\/0003-4819-77-6-861"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.15","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.kjms.2013.05.002","article-title":"Hodgkin\u2019s lymphoma-related vanishing bile duct syndrome: a case report and literature review","volume":"29","author":"Wong","year":"2013","journal-title":"Kaohsiung J Med Sci"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4103\/1319-3767.121037","article-title":"Vanishing bile duct syndrome in a Hodgkin\u2019s lymphoma patient with fatal outcome despite lymphoma remission","volume":"19","author":"Aleem","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.17","first-page":"3435","article-title":"Association between glutathione S-transferase genotypes and Hodgkin\u2019s lymphoma risk and prognosis","volume":"9","author":"Hohaus","year":"2003","journal-title":"Clin Cancer Res"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.18","DOI":"10.1097\/00001813-200202000-00011"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.19","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(19880515)61:10<1988::AID-CNCR2820611010>3.0.CO;2-5","article-title":"Fatal hepatic vascular toxicity of DTIC. Is it really a rare event?","volume":"61","author":"Ceci","year":"1988","journal-title":"Cancer"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.20","DOI":"10.1002\/jso.2930270415"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.21","first-page":"219","article-title":"Allergy-induced hepatic toxicity associated with dacarbazine","volume":"71","author":"McClay","year":"1987","journal-title":"Cancer Treat Rep"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.22","DOI":"10.1053\/jhep.1996.v23.pm0008621135"},{"doi-asserted-by":"publisher","key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.23","DOI":"10.1056\/NEJM199106273242604"},{"key":"2025082706473032000_2018.jul27_1.bcr-2018-225474.24","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/1319-3767.207711","article-title":"Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: a prospective study","volume":"23","author":"Nabi","year":"2017","journal-title":"Saudi J Gastroenterol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2018-225474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T13:47:41Z","timestamp":1756302461000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2018-225474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,30]]},"references-count":24,"alternative-id":["10.1136\/bcr-2018-225474"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2018-225474","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2018,7,30]]}}}